Suppr超能文献

癌症生物学中的O-连接N-乙酰葡糖胺糖基化:连接代谢与信号传导

O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.

作者信息

Ferrer Christina M, Sodi Valerie L, Reginato Mauricio J

机构信息

Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.

Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.

出版信息

J Mol Biol. 2016 Aug 14;428(16):3282-3294. doi: 10.1016/j.jmb.2016.05.028. Epub 2016 Jun 23.

Abstract

The hexosamine biosynthetic pathway (HBP) is highly dependent on multiple metabolic nutrients including glucose, glutamine, and acetyl-CoA. Increased flux through HBP leads to elevated post-translational addition of β-D-N-acetylglucosamine sugars to nuclear and cytoplasmic proteins. Increased total O-GlcNAcylation is emerging as a general characteristic of cancer cells, and recent studies suggest that O-GlcNAcylation is a central communicator of nutritional status to control key signaling and metabolic pathways that regulate multiple cancer cell phenotypes. This review summarizes our current understanding of changes of O-GlcNAc cycling enzymes in cancer, the role of O-GlcNAcylation in tumorigenesis, and the current challenges in targeting this pathway therapeutically.

摘要

己糖胺生物合成途径(HBP)高度依赖多种代谢营养物质,包括葡萄糖、谷氨酰胺和乙酰辅酶A。HBP通量增加会导致β-D-N-乙酰葡糖胺糖在核蛋白和胞质蛋白上的翻译后添加增加。总O-连接N-乙酰葡糖胺化增加正成为癌细胞的一个普遍特征,最近的研究表明,O-连接N-乙酰葡糖胺化是营养状态的核心传递者,可控制调节多种癌细胞表型的关键信号和代谢途径。本综述总结了我们目前对癌症中O-连接N-乙酰葡糖胺循环酶变化的理解、O-连接N-乙酰葡糖胺化在肿瘤发生中的作用以及在治疗上靶向该途径目前面临的挑战。

相似文献

1
O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
J Mol Biol. 2016 Aug 14;428(16):3282-3294. doi: 10.1016/j.jmb.2016.05.028. Epub 2016 Jun 23.
2
Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
J Biol Chem. 2016 Jun 17;291(25):12917-29. doi: 10.1074/jbc.M116.729236. Epub 2016 Apr 18.
3
Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity.
Adv Cancer Res. 2023;157:195-228. doi: 10.1016/bs.acr.2022.06.002. Epub 2022 Jul 28.
4
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
J Bioenerg Biomembr. 2018 Jun;50(3):155-173. doi: 10.1007/s10863-018-9751-2. Epub 2018 Mar 29.
5
Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Adv Cancer Res. 2019;142:23-62. doi: 10.1016/bs.acr.2019.01.002. Epub 2019 Feb 27.
6
On a sugar high: Role of O-GlcNAcylation in cancer.
J Biol Chem. 2023 Nov;299(11):105344. doi: 10.1016/j.jbc.2023.105344. Epub 2023 Oct 12.
7
Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
Biochim Biophys Acta Gen Subj. 2023 Jan;1867(1):130250. doi: 10.1016/j.bbagen.2022.130250. Epub 2022 Oct 10.
8
First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in mouse heart.
J Biol Chem. 2020 Feb 14;295(7):2018-2033. doi: 10.1074/jbc.RA119.010565. Epub 2020 Jan 8.
9
Cancer metabolism: cross talk between signaling and O-GlcNAcylation.
Methods Mol Biol. 2014;1176:73-88. doi: 10.1007/978-1-4939-0992-6_7.
10
Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
BMC Biol. 2019 Jul 4;17(1):52. doi: 10.1186/s12915-019-0671-3.

引用本文的文献

1
Cell cycle regulation in cancer cells by O-GlcNAcylation.
Glycoconj J. 2025 Aug 18. doi: 10.1007/s10719-025-10189-8.
3
A ROS-mediated oxidation-O-GlcNAcylation cascade governs ferroptosis.
Nat Cell Biol. 2025 Jul 18. doi: 10.1038/s41556-025-01722-w.
4
Downregulation of O-GlcNAcylation enhances etoposide-induced p53-mediated apoptosis in HepG2 human liver cancer cells.
FEBS Open Bio. 2025 Jul;15(7):1176-1188. doi: 10.1002/2211-5463.70028. Epub 2025 Apr 16.
6
hsa-mir-483-3p modulates delayed breast cancer recurrence.
Sci Rep. 2025 Jan 3;15(1):693. doi: 10.1038/s41598-024-84437-6.
7
8
Exploring diabesity pathophysiology through proteomic analysis using .
Front Endocrinol (Lausanne). 2024 Oct 30;15:1383520. doi: 10.3389/fendo.2024.1383520. eCollection 2024.
10
ACSS2 regulates ferroptosis in an E2F1-dependent manner in breast cancer brain metastatic cells.
bioRxiv. 2024 Oct 21:2024.10.18.619082. doi: 10.1101/2024.10.18.619082.

本文引用的文献

1
O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway.
Oncogene. 2017 Jan 26;36(4):559-569. doi: 10.1038/onc.2016.228. Epub 2016 Jun 27.
2
Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
J Biol Chem. 2016 Jun 17;291(25):12917-29. doi: 10.1074/jbc.M116.729236. Epub 2016 Apr 18.
3
Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
Nat Immunol. 2016 Jun;17(6):712-20. doi: 10.1038/ni.3439. Epub 2016 Apr 25.
4
Tumor angiogenesis--characteristics of tumor endothelial cells.
Int J Clin Oncol. 2016 Apr;21(2):206-212. doi: 10.1007/s10147-016-0957-1. Epub 2016 Feb 15.
5
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Oncotarget. 2016 Mar 15;7(11):12464-76. doi: 10.18632/oncotarget.7039.
6
Disruption of O-linked N-Acetylglucosamine Signaling Induces ER Stress and β Cell Failure.
Cell Rep. 2015 Dec 22;13(11):2527-2538. doi: 10.1016/j.celrep.2015.11.020. Epub 2015 Dec 8.
7
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth.
Nat Commun. 2015 Sep 24;6:8468. doi: 10.1038/ncomms9468.
8
MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy.
Mol Cell Biochem. 2015 Dec;410(1-2):101-10. doi: 10.1007/s11010-015-2542-8. Epub 2015 Aug 29.
10
The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1.
Cell. 2015 Jul 16;162(2):259-270. doi: 10.1016/j.cell.2015.06.017. Epub 2015 Jul 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验